Sign in

CIK 0001680048

  • Non-accelerated filer
  • Smaller reporting company

MUSTANG BIO, INC.

Sign in to watch
Ticker
MBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473828760
Phone
+1 781-652-4500
Business address
95 SAWYER RD, SUITE 110, WALTHAM, MA, 02453
  1. 4 Grant or award Director acquired 13,774 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 61,000 shares (grant or award)
  3. 4 Grant or award Director acquired 13,774 shares (grant or award)
  4. 4 Grant or award Director acquired 13,774 shares (grant or award)
  5. 4 Open-market sale President and CEO sold 12,373 shares at $3.04 ($37,614)
  6. 4 Open-market sale SVP, Fin. & Corp. Controller sold 20,721 shares at an average $3.20 ($66,282)
  7. 4 Open-market buy President and CEO bought 165,562 shares at $3.12 ($516,553)
  8. 4 Grant or award Director acquired 1,043 shares (grant or award)
  9. 4 Grant or award SVP, Fin. & Corp. Controller acquired 22,500 shares (grant or award)
  10. 4/A Open-market buy Director bought 100,000 shares at $2.66 ($266,000)
  11. 4/A Grant or award Director acquired 17,442 shares (grant or award)
  12. 4 Open-market buy President and CEO bought 100,000 shares at $2.91 ($291,000)
  13. 4 Open-market buy Director bought 100,000 shares at $2.66 ($266,000)
  14. 4 Grant or award Director acquired 16,611 shares (grant or award)
  15. 4 Grant or award Director acquired 16,611 shares (grant or award)
  16. 4 Grant or award Director acquired 16,611 shares (grant or award)
  17. 4 Grant or award Director acquired 16,611 shares (grant or award)
  18. 4 Grant or award Director acquired 16,611 shares (grant or award)
  19. 4 Open-market buy President and CEO bought 153,846 shares at $3.25 ($500,000)
  20. 4 Open-market buy President and CEO bought 180,000 shares at an average $2.96 ($532,800)

Page 3 of 5 · 85 filings